Marker Therapeutics, Inc. MRKR

Set alert

Price alert · MRKR

All alert types
0.90 USD -0.08 -8.05%

At close · Nov 2

0.90 0.00 -0.21%

After hours · Nov 2, 4:00 PM ET

Bid
0.90 × 6
Ask
0.90 × 6
0.88 Day range 0.97
0.84 52-week range 2.46
YTD
-39.52%
1 year
-8.98%
Open
0.96
Prev close
0.98
Mkt cap
15.02M
Vol
265.72K
Avg vol
108.53K
EPS
-0.38
P/E
0.00
Div yield
0.00%
More statistics
Low
0.88
High
0.97
Forward P/E
-2.34
Beta
1.49
Short ratio
1.55
Inst. own
22.44%
Dividend
0.00
Ex-div date
Earnings
Mar 27, 2024
50-d avg
3.71
200-d avg
3.97
1y target
19.00

3M chart

Chart tools
Interval

Signals (19)
NameDateAgo
MACD: Sell SignalNov 2, 202620 hours ago
MACD: Buy SignalOct 28, 20265 days ago
MACD: Sell SignalOct 27, 20266 days ago
SMA: BearishOct 22, 20261 week ago
SMA: BearishOct 20, 20261 week ago
SMA: BullishOct 19, 20262 weeks ago
SMA: BullishOct 19, 20262 weeks ago
MACD: Buy SignalOct 19, 20262 weeks ago
MACD: Sell SignalSep 25, 20261 month ago
MACD: Buy SignalSep 23, 20261 month ago
SMA: BearishSep 9, 20261 month ago
SMA: BullishSep 8, 20261 month ago
MACD: Sell SignalSep 3, 20262 months ago
SMA: BearishSep 1, 20262 months ago
SMA: BullishAug 21, 20262 months ago
SMA: BullishAug 21, 20262 months ago
SMA: BearishAug 20, 20262 months ago
SMA: BullishAug 19, 20262 months ago
MACD: Buy SignalAug 12, 20262 months ago

Analyst view

Consensus: strong buy

Strong buy
Price target (mean) 19.00
Ratings (0m) 1 1 buy · 0 hold · 0 sell
  • Strong buy0
  • Buy1
  • Hold0
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 1
  • 1 month ago 1
  • 2 months ago 1

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

MRKR analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.28-0.28 – -0.280.000.0%1.00M0.0%1
Next quarter-0.32-0.32 – -0.32-0.27-18.5%1.00M-19.6%1
Current year-1.05-1.05 – -1.050.000.0%5.34M0.0%1
Next year-2.19-2.19 – -2.19-1.05-108.6%4.00M-25.1%1

Upgrades and downgrades

The latest rating changes

MRKR analyst upgrades and downgrades
DateFirmActionFromTo
Apr 30, 2024Ladenburg ThalmannInitiated—Buy